The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for January 29, 2021
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA


Brakke Consulting News
2021 Industry Overview – register now

Earnings News

Other News
Branford Castle
Canopy Growth
Franchise Group
Landini Giunini
Mars Petcare
Miller Veterinary Supply
Partner in Pet Food
Pet Naturals
Pet Supplies Plus
Proteon Pharmaceuticals
Pulse Veterinary Technologies
Sentinel Capital Partners
VetStem Biopharma

SWVS 2021 will be LIVE and IN-PERSON!
San Antonio, Texas – Henry B. Gonzalez Convention Center
September 23-26, 2021
Early Bird Registration — Now Until July 15th

FURther Together  – Registration is NOW OPEN! Southwest Veterinary Symposium — a partnership of the Arkansas, Louisiana, New Mexico, Oklahoma and Texas Veterinary Medicine Associations which provides continuing education for veterinary professionals. Join us live in-person this September in San Antonio, Texas, where you can learn about the latest innovations and products while exploring our exhibit hall, network with other veterinary professionals, and choose from more than 400+ hours of quality CE/RACE approved sessions.


  • Vetoquinol reported results for the full year 2020. Sales were EUR 427.5 million ($525 million), up 8% as reported and up 11% at constant exchange rates. (Business Wire)


New research on how veterinarians have been affected by the COVID-19 pandemic and their plans for the post-pandemic world will be an important feature of the annual Brakke Consulting Industry Overview, to be presented in a 90-minute webinar on Tuesday, Feb. 23 beginning at 11 am EST.

The new research examines the role of such things as curbside appointments and telemedicine, and how veterinarians plan to deploy them post-pandemic.  We also look at the impact of COVID-19 on the veterinary staff during this trying year, as well as make our predictions on what’s ahead for the industry in 2021.  There will also be an opportunity for questions from the audience.

In addition to the new research findings, the Overview will cover:

  • Top animal health company revenues, growth, and new product performance
  • A special analysis of changes in ecommerce and pet medication sales
  • Status of veterinary practice consolidation
  • Data on pet adoptions and pet population during the pandemic
  • New perspectives on the evolution of veterinary distribution
  • African Swine Fever, pandemic-driven packing plant closures and the future of technology on the farm animal market

The Brakke Industry Overview is an information-packed presentation geared to the interests of executive leadership, sales and marketing managers, financial executives and others involved in the industry.  The cost of attending the online Overview this year is reduced to $199.  To register, click here. Or, you can call Amanda McDavid, (336) 396-3916.  We look forward to having you join us.


  • Zoetis announced the launch of Poulvac Procerta HVT-IBD recombinant vaccine, which provides early protection against the contemporary infectious bursal disease (IBD) viruses confronting U.S. broilers. (WattAgNet)
  • Elanco announced the next step in its ongoing efforts to improve operational efficiency. Elanco intends to close R&D sites in Manukau, New Zealand and Cuxhaven, Germany, subject to appropriate local consultation processes. Elanco will also reduce duplication and optimize structures in U.S. operations, Marketing, Manufacturing and Quality central functions, and administrative areas. The restructuring will result in the elimination of approximately 350 positions around the world. (company press release)
  • VetriScience announced the launch of Composure Long Lasting, an all-day calming support supplement for dogs with separation anxiety, clinically shown to last for up to eight hours. (company press release)
  • Mars Petcare announced it will spend $145 million to grow its Fort Smith, Arkansas, manufacturing site. The funds will add two new production lines to the facility and increase its footprint by more than 200,000 sf, increasing production capacity by more than 40 percent. (Veterinary Practice News)
  • VetStem Biopharma announced it has executed several royalty-bearing licenses for its adipose-derived stem cell therapy with multiple undisclosed human and veterinary stem cell companies. VetStem holds exclusive global veterinary licenses to a portfolio of issued patents in the field of regenerative medicine, and owns a number of patents and patent applications. (IHS Markit Connect)
  • Zomedica announced that it has signed an agreement with Miller Veterinary Supply for the distribution of TRUFORMA, Zomedica’s first product, planned to begin sales on March 30, 2021. (GlobeNewsWire)
  • VolitionRx announced the opening of a new 10,000 sf manufacturing site in Belgium. The plant will be dedicated to large-scale production of all the key raw materials for the firm’s Nu. Q products, such as recombinant nucleosomes and antibodies. Finished products such as the recently launched Nu.Q Vet Cancer Screening Test will also be produced at the site. (IHS Markit Connect)
  • Sentinel Capital Partners announced plans to sell Pet Supplies Plus to Franchise Group, Inc. in a deal valued at $700 million, after acquiring Pet Supplies Plus two years ago. Pet Supplies Plus’s footprint includes 537 stores in 36 states. (Pet Business)
  • Pet Naturals introduced Impawsibly Good Treats for dogs. According to the company the treats are the first multi-flavor line of plant-based dog treats. Pet Naturals also announced the debut of Heartibles Heart Healthy Dog Treats with taurine and omega-3 fatty acids. (company press release)
  • Private equity firm Branford Castle announced that its portfolio company, Pulse Veterinary Technologies LLC (PulseVet), has acquired NeoPulse GmbH from Switalis, a leading Switzerland-based shock wave therapy device manufacturer. Financial terms were not disclosed. (company press release)
  • Skretting and Proteon Pharmaceuticals announced a collaboration to address health challenges in the aquaculture industry by developing products using Proteon’s bacteriophage technology. The companies will initially co-develop a product for Vibrio, one of the most prevalent problems across the global aquaculture sector. (IHS Markit Connect)
  • Canopy Growth Corporation announced the launch of Martha Stewart CBD for Pet, a new line of CBD wellness solutions for canines. The product portfolio includes oil drops and soft-baked chews in three gourmet flavor combinations and formulas – Wellness, Calm and Mobility. (PRnewswire)
  • EU Alivira Animal Health announced it has received a certificate of suitability from the European Directorate for the Quality of Medicines (EDQM) for its generic active pharmaceutical ingredient (API) diclazuril in the EU. Diclazuril is an antiprotozoal drug for treating coccidiosis in livestock; it is also used in horses to treat equine protozoal myeloencephalitis caused by Sarcocystis neurona. The latest API authorization is Alivira’s eleventh from the EDQM.  (IHS Markit Connect)
  • EU TheraVet announced it has been awarded minor use/minor species designation for Visco-Vet – a hyaluronan-based visco-regenerative gel supplement – by the European Medicines Agency for the early treatment of CCL deficiency in dogs. (IHS Markit Connect)
  • ITALY Partner in Pet Food announced it has acquired Landini Giunini, the largest private label dry pet food manufacturer in Italy. Financial terms were not disclosed. (GlobalPets)



  • US – PORK SECURITY The National Pork Board announced the launch of AgView, a technology solution to help the U.S. pork industry respond faster than ever before possible in the event of a foreign animal disease outbreak. The web-based tool will allow participating producers to easily share their farm’s FAD status updates and pig movement data with state animal health officials. The opt-in, no-fee technology — funded by the Pork Checkoff — will allow for contact-tracing of infected animals to help rapidly contain or regionalize a potential FAD outbreak. (AgriNews)
  • WORLD – VETERINARY MEDICINES DATABASE The World Veterinary Association (WVA) and international charity Brooke announced a collaboration to develop the first-ever global list of essential veterinary medicines for working equines and livestock.  The list will contain basic medicines and vaccinations, selected for their relevance, efficacy and cost-effectiveness that should be available in every country to every veterinarian.  The project builds on the success of the World Small Animal Veterinary Association’s (WSAVA) list of essential medicines for dogs and cats. (WVA)

Last year at this time, I had just returned from VMX and was eagerly planning my upcoming trip to Western Veterinary Conference in February.  People were starting to talk about this new coronavirus that had started to spread across the globe, but here in the USA there were no travel restrictions and no concerns about attending industry conferences.  Then, not long after WVC, the country began shutting down and conferences were cancelled.

By late summer, many conferences had found their footing in the virtual world, so we were able to meet up after a fashion.  However, despite their admirable efforts to offer ways to interact virtually with colleagues and prospective clients, networking has suffered, for me and likely for many others. There’s nothing like a gathering of thousands of your peers to chance running into someone and spending 5 or 10 minutes catching up.

There is much to be optimistic about in 2021, with multiple SARS-CoV-2 vaccines now rolling out.  I am hopeful that by this summer we will be living in a more “normal” world.  VMX has moved from January to June, and WVC from February to September, in order to put on in-person events (although still offering virtual events as well for those not yet ready to travel); other summer & fall events will also be available.  I’m looking forward to seeing all of you in the flesh again.

Lynn Fondon

Last week, we asked what you most look forward to doing more of in 2021 that you have delayed doing in 2020 because of the COVID-19 situation.  Vacationing was the #1 response, mentioned by one-quarter of you, followed by international air travel and face-to-face time with family and friends (at 19% each). Attending a large sporting event or concert was chosen by 17%.  Looks like the tourism industry should bounce back once restrictions are lifted.

This week
This week, let’s hear from you about your networking efforts.  Has the inability to attend industry  conferences and meet with others in person affected your professional networking?


en_USEnglish (United States)